Core Insights - 30 companies listed on the ChiNext board have released their performance forecasts for the first three quarters, with 24 companies expecting profit increases, representing 80.00% of the total [1] - The overall proportion of companies with positive forecasts is 86.67%, with 2 companies expecting to turn a profit and 4 companies forecasting profit declines [1] Performance Forecasts - Among the companies expecting profit increases, 10 companies anticipate a net profit growth exceeding 100%, while 6 companies expect growth between 50% and 100% [1] - ShuoBeide (300322) leads with a projected net profit growth of 1285.82%, followed by Chenguang Biotech (300138) at 372.80% and Ice River Network (300533) at 207.09% [1] Market Performance - Stocks with expected profit doubling have seen an average increase of 102.14% year-to-date, with notable performers including Zhenyu Technology (300953) up 256.27%, Jinli Permanent Magnet (300748) up 142.52%, and Ice River Network (300533) up 94.89% [1] - Recent performance over the last five days shows Jinli Permanent Magnet (300748) up 25.75%, Feirongda (300602) up 11.28%, and Chenguang Biotech (300138) up 8.31% [1] Company Performance Table - A detailed table lists companies with their respective codes, expected profit growth percentages, latest closing prices, year-to-date performance, and industry classifications [1][2]

6 证券研究报告 点评报告 2025 年 10 月 15 日 晨会纪要 核[心Ta观bl点e_：Summary] 一、产业综合组： 国内最大的芯片 CP 测试商伟测科技公布了 2025 年第三季度的部分经营数据， 2025 年 7-9 月实现合并营业收入 44,832.45 万元，较去年同期增加 44.40%。公 司 2025 年 1-9 月实现合并营业收入 108,257.71 万元，较去年同期增加 46.22%。 同日国内 AOIT 用 SOC 芯片大厂瑞芯微也公布了 2025 年前三季度业绩预告，实 现归属于母公司净利润 76,000 万元到 80,000 万元，同比增长 116%到 127%。扣 非后净利润 73,500 万元到 77,500 万元，同比增长 114%到 126%。虽然按此测算 瑞芯微第三季度单季的净利润增速只有约 50%，明显低于上半年的业绩增速，但 主要是由于 DDR4 存储芯片从供应短缺到价格暴涨，促使部分客户中高端 AIoT 产品向 DDR5 转型，后续产品交付会快速起量，因此总体看国内半导体产业三季 度的业绩增速呈加速趋势，继续看好半导体产业景气度的持续提升。 宗申动力发布 ...

Core Points - The stock price of Morning Light Bio has increased by 66.12% this year, with a recent rise of 8.85% in the last five trading days [2] - The company reported a revenue of 3.658 billion yuan for the first half of 2025, representing a year-on-year growth of 4.77%, and a net profit of 215 million yuan, which is a significant increase of 115.33% year-on-year [3] - Morning Light Bio has a market capitalization of 6.894 billion yuan and a trading volume of 96.9973 million yuan as of October 15 [1] Financial Performance - The company has seen a net outflow of 1.5082 million yuan in principal funds, with large orders accounting for 16.83% of purchases and 19.20% of sales [1] - The company has cumulatively distributed 516 million yuan in dividends since its A-share listing, with 213 million yuan distributed in the last three years [4] Shareholder Information - As of June 30, the number of shareholders for Morning Light Bio is 15,800, a decrease of 35.12% from the previous period, while the average circulating shares per person increased by 54.14% to 25,224 shares [3] - The top ten circulating shareholders have changed, with the China Europe Times Pioneer Stock A exiting the list [4]

Core Insights - 27 companies listed on the ChiNext board have released their performance forecasts for the first three quarters, with 23 companies expecting profit increases, representing 85.19% of the total [1] - The overall proportion of companies with positive forecasts is 92.59%, with 2 companies expecting to turn a profit and 2 companies forecasting profit declines [1] Performance Forecasts - Among the companies expecting profit increases, 9 companies anticipate a net profit growth of over 100%, while 6 companies expect a growth between 50% and 100% [1] - The company with the highest expected net profit growth is Morning Light Bio, forecasting a median increase of 372.80% [1] - Other notable companies include Glacier Network and Bai Ao Intelligent, with expected net profit growths of 207.09% and 184.12%, respectively [1] Company Performance Data - The following companies are highlighted for their significant expected profit increases: - Morning Light Bio (Code: 300138) - Expected net profit growth: 372.80%, Latest closing price: 13.99, Year-to-date change: 62.33% [1] - Glacier Network (Code: 300533) - Expected net profit growth: 207.09%, Latest closing price: 38.10, Year-to-date change: 92.81% [1] - Bai Ao Intelligent (Code: 300836) - Expected net profit growth: 184.12%, Latest closing price: 56.53, Year-to-date change: 95.40% [1] - Other companies with notable growth include Chuan Jin Nuo (171.61%), Jin Li Yong (168.00%), and Bo Teng (139.09%) [1]

Summary of the Conference Call for Morning Bio Industry Overview - The industry is experiencing a recovery in supply-demand dynamics, with a decrease in raw material planting areas and a continuous increase in demand. The trend towards natural product substitution is evident, leading to a forecasted moderate recovery in industry profitability over the next few years [2][7]. Company Performance - In the first three quarters of 2025, Morning Bio's main products, including chili red and chili extract, saw steady sales growth and significant improvement in gross margins. The overall operational trend is similar to the first half of the year [2]. - The company achieved a net profit of between 63 million and 99 million in the third quarter, marking a return to profitability due to increased revenue and gross margins from direct sales products and a recovery in the cottonseed business [4]. - Various products reached historical sales highs, although there remains a gap compared to the peaks of 2022-2023, primarily due to some products being at historical low prices and industry capacity recovery [6]. Product Insights - Chili red sales grew by 40% year-on-year in the first half of 2025, with an expected annual growth rate stabilizing around 20%. The company anticipates maintaining a compound annual growth rate of about 10% in the long term [10]. - The chili extract's gross margin is currently around 20%, with optimistic expectations for raw material price increases, which could significantly improve product profitability [11]. - The company has expanded its health food production capacity with a new facility that adds 1 billion units, expected to generate revenue of 220 million to 300 million in 2026 [3][21]. Strategic Initiatives - To address potential raw material supply tightness, the company has taken proactive measures, including reserving low-cost raw materials and expanding overseas sourcing in regions like Africa, India, and Myanmar [8]. - The company is also focusing on technological reserves to meet downstream demand, including the development of water-soluble pigments and customized application products [9]. Market Position and Future Outlook - The market share for chili red is projected to increase to over 50% in 2025, with a mid-term goal of over 80%. The industry is expected to return to a natural growth rate of 10-20% in the coming years [2][20]. - The cottonseed business is expected to maintain stable revenue and profitability, with a net profit of at least 5,000 to 6,000 per ton, indicating a favorable outlook for the next year [20]. - The health food sector is viewed as a continuously developing and rapidly growing market, with Morning Bio aiming to provide high-quality raw materials and products while creating long-term profits for shareholders [23]. Additional Insights - The company has seen a significant increase in sales of other products, such as tomato lycopene and stevia, with sales growth of approximately 50% in the first half of 2025 [17]. - The company is also exploring self-branded products and expanding its market presence through various sales channels, including online platforms [22]. This summary encapsulates the key points from the conference call, highlighting the company's performance, strategic initiatives, and future outlook within the industry.

Core Viewpoint - Chenguang Biotech (300138) announced that the company and its subsidiaries have no overdue external guarantees [1] Group 1 - The announcement was made on the evening of October 14 [1] - The company reassured stakeholders regarding its financial obligations and risk management practices [1]

Core Viewpoint - The A-share market is witnessing a significant number of companies announcing performance forecasts for the first three quarters of 2025, with most companies expecting substantial profit increases compared to the previous year [1]. Group 1: Company Performance Forecasts - Xinda Co. expects a net profit of 180 million to 205 million yuan for the first three quarters of 2025, representing an increase of 2807.87% to 3211.74% compared to 6.19 million yuan in the same period last year, driven by rising product prices and operational reforms [2]. - Jiantou Energy anticipates a net profit of approximately 1.583 billion yuan for the first three quarters of 2025, a year-on-year increase of about 231.75%, attributed to lower coal prices and improved profitability from its thermal power business [2]. - Xianggang Technology forecasts a net profit of 94 million to 100 million yuan, reflecting an increase of 182% to 200% compared to the previous year, due to market expansion and improved operational efficiency [3]. - Zijang Enterprises expects a net profit of 897 million to 1 billion yuan, an increase of 70% to 90% year-on-year, driven by innovation, green transformation, and improved production efficiency [4]. - Suihengyun A predicts a net profit of 345 million to 515 million yuan, representing a growth of 87.83% to 180.38% compared to the previous year, influenced by the commissioning of solar projects and rising electricity prices [5]. Group 2: Stock Market Reactions - Several companies with positive performance forecasts have seen significant stock price increases, such as Chuangjiang New Materials, which reported a projected net profit of 350 million to 380 million yuan, a year-on-year increase of 2057.62% to 2242.56% [6]. - Yuegui Co. also experienced a strong stock price surge, with an expected net profit of 420 million to 470 million yuan, reflecting an increase of 86.87% to 109.11% compared to the previous year, driven by cost reduction and rising product prices [7]. - Chenguang Biological reported a projected net profit of 278 million to 314 million yuan, a year-on-year increase of 344.05% to 401.55%, attributed to improved revenue and profitability in its main product lines [7].

Core Viewpoint - The A-share market is witnessing a significant number of companies announcing substantial profit increases for the first three quarters of 2025, with many companies projecting profit growth exceeding 20 times compared to the previous year [2][4]. Group 1: Company Performance Highlights - XianDa Co. expects a net profit of 180 million to 205 million yuan for the first three quarters of 2025, representing an increase of 2807.87% to 3211.74% year-on-year, driven by rising market prices of its main product and operational reforms [4]. - JianTou Energy anticipates a net profit of approximately 1.583 billion yuan, a year-on-year increase of about 231.75%, attributed to lower coal prices and improved profitability from its power generation subsidiaries [5]. - XiangGang Technology projects a net profit of 94 million to 100 million yuan, reflecting an increase of 182% to 200% year-on-year, due to market expansion and enhanced operational efficiency [5]. - ZiJiang Enterprises expects a net profit of 897 million to 1.002 billion yuan, a growth of 70% to 90% year-on-year, driven by innovation, green transformation, and improved production efficiency [6]. - SuiHengYun A forecasts a net profit of 345 million to 515 million yuan, an increase of 87.83% to 180.38% year-on-year, supported by the launch of new projects and rising investment income [7]. Group 2: Market Reactions - Several companies with positive earnings forecasts have seen significant stock price increases, such as ChuJiang New Materials, which reported a projected net profit of 350 million to 380 million yuan, marking a year-on-year growth of 2057.62% to 2242.56% [9]. - YueGui Co. also experienced a strong stock performance, with a projected net profit of 420 million to 470 million yuan, reflecting an increase of 86.87% to 109.11% year-on-year, driven by cost reduction and rising product prices [9]. - Chenguang Biological reported a projected net profit of 278 million to 314 million yuan, a year-on-year increase of 344.05% to 401.55%, attributed to improved revenue from its main products and a recovery in its cottonseed business [10].

短期看主要产品盈利水平持续修复，中长期公司前瞻布局成效逐步释放，合成食用色素禁用政策有望推 动行业景气度持续提升。24 年多个主要产品底部周期叠加造成低基数，随着产品价格逐步回暖，公司 将稳步进入盈利修复通道。未来几年，公司储备的梯队产品及海外基地建设所形成的长期竞争力，将有 望陆续展现成效。此外，伴随美国FDA 至2026 年底逐步淘汰合成食用色素，天然色素需求与行业景气 度有望持续攀升，带动公司需求与盈利进一步增长。 事件：公司发布2025 年前三季度业绩预告，预计25 年1-9 月归母净利润为2.78-3.14 亿元，同比增长 344.05%-401.55%；扣非归母净利润为2.18-2.54 亿元，同比增长1398.00%-1645.38%。 经营持续向好，棉籽与植提业务盈利均有改善。单25Q3 看，预计公司归母净利润为0.63-0.99 亿元，预 计扣非归母净利润为0.34-0.70 亿元，较去年同期显著改善（24Q3 归母净利润为-0.37 亿元，扣非归母净 利润为-0.65 亿元）。今年以来，棉籽类产品价格整体回暖，公司严格执行对锁经营模式，保持稳健运 营；植提业务方面，多个主要产品底部回暖趋势 ...

Core Insights - The overall performance of A-share listed companies for the first three quarters of 2025 is positive, with over 84% of companies reporting favorable earnings forecasts, indicating a recovery in profitability amid supportive economic policies and structural optimization [1][2]. Group 1: Earnings Performance - As of October 14, 2025, 72 companies have released earnings forecasts, with 18 companies expecting slight increases, 4 companies turning losses into profits, and 41 companies forecasting significant profit growth [2]. - Notably, 22 companies are projected to achieve profits exceeding 500 million yuan, with New China Life Insurance leading at a net profit of 32.05 billion yuan, a year-on-year increase of 45%-65% [2]. - Other companies with substantial profits include Luxshare Precision at 11.12 billion yuan (20%-25% growth), Salt Lake Industry at 4.5 billion yuan, and Yuexiu Capital at 3.008 billion yuan [2]. Group 2: Profit Growth Rates - 22 companies are expected to see a year-on-year profit growth of over 100%, with 5 companies exceeding 300% growth [3]. - Chujiang New Materials is highlighted as the "profit growth king," with an estimated net profit of 350-380 million yuan, reflecting a staggering increase of 2057.62%-2242.56% [3]. - Other notable performers include Yinglian Co. (1602.05% growth), Guangdong Mingzhu (964.95%), and Liming Co. (659.48%) [3]. Group 3: Sector Performance - The semiconductor industry is experiencing a significant recovery, with the global semiconductor market reaching $346 billion in the first half of 2025, a year-on-year increase of 18.9% [3]. - Changchuan Technology, a leading semiconductor equipment company, anticipates a net profit of 827-877 million yuan, marking a year-on-year increase of 131.39%-145.38% [3]. - Yangjie Technology expects a net profit of 937-1,004 million yuan, driven by strong growth in automotive electronics, artificial intelligence, and consumer electronics [3]. Group 4: Regional Performance - Shandong stocks have shown resilience, particularly in traditional industries and resource-based enterprises, achieving growth through internal reforms and cost reductions [4]. - Jinling Mining reported a revenue of 1.247 billion yuan, a 12.98% increase, with a net profit of 220 million yuan, up 47.09% [4]. - Shandong Steel successfully turned losses into profits by implementing cost control measures, achieving a gross margin increase to 6.02%, up 4.15 percentage points [4]. Group 5: Market Trends and Opportunities - The current market is entering a "policy + performance" window, with earnings becoming the core criterion for selecting stocks [5]. - The technology sector is experiencing a broad rally, with significant growth in computing power and AI-related stocks, although there is internal differentiation based on earnings support [5]. - The gaming sector is also highlighted, with expectations of recovery driven by normalized issuance of game licenses and strong product pipelines from leading companies [5][6].